Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sorry Theorysuit, I meant FeMike not you.
You and Theorysuit are shameless.
Disagree. Lots of pressure applied with the promise of UK Sawston and Advent jobs, as Mr Brown suspects. Plus the various charities and Kings strong arming local politicians. LP and the bunch are no strangers to working the political system. There's a reason they waited all this time to submit until the EMA umbilical cord was cut, IMO.
>>If the MAA is granted, rest assured, it has undergone microscopic scrutiny,
You have got to stop calling this one a "Pre revenue". That infers it's a normal biotech. For ten years various people have been calling for revenue coming in every year. It never happens! Joan said $100M was supposed to happen two years ago. LP doesn't do cc's because she doesn't want to get caught having to explain anything. Instead you people here do it for her. It's a joke.
That's total BS! I can't recall any active Pll/lll that didn't hold quarterly calls, let alone a U.S. one claiming great success and with a manufacturing facility in the UK. What a joke.
I said "supposedly", Rusty.
More apologists. This isn't some start up fractionating rats brains! It's a biotech supposedly getting ready for commercialization. Shame on you, RustyMike...Shame on you!
>>It is not unusual at all for prerevenue companies, especially in the biotech space, to not have quarterly conference calls.
Again, that's not what NWBO's PR says. They make PIP seem forced on them while you make it appear like a gift to shareholders.
>>The development, regulatory review and regulatory approval of a PIP is a pre-requisite for application for approval of a new medicine for adult patients, such as DCVax®-L.
>>Under applicable UK law, when a new medicine is developed for adult patients, that medicine must also be tested for potential application to pediatric patients.
>>The approval may include a deferral allowing the pediatric clinical trials to actually be carried out after the MAA has been submitted, but the PIP approval itself must have been received before an MAA can be filed and go through compliance check.
>>The Company’s approved PIP includes a deferral under which the pediatric trials are anticipated to be undertaken after an MAA application has been submitted.
Last time the share price ran on a pump, as is obvious since never any revenues, partner, or buyout since.
How do you think the share price is going to rise when they desperately need cash and never even briefed investors on their commercial revenue plans / projections? Investors haven't even seen the CEO for five years! LOL. If somehow MHRA and NICE green lights L they'll raise cash at 50 cents boasting of a 30% premium. Watch and learn.
Okay then 50,000,000!!! LOL
You disciples throw around tens of millions of shares like it means nothing!
LOL. A little confusion about MHRA PIP procedure brought on by a poorly written PR, and suddenly their master manipulators. Can't make it up.
Ahahaha!!! Should be .29 by then with another 100M shares out. Might double to .58 on approval. Eye rolls.
>>Come August if we still haven't heard a peep, okay, maybe you can start speculating.
Diaper check for George please.
Without the NICE nod an MHRA approval will be next to meaningless for the share price.
Smitty had to contact MHRA for clarification so what do you think?
I have no desire to contact MHRA. It's really NWBO's job to properly brief investors, assuming they want to raise cash at better prices, of course.
Smitty, please share that MHRA email here. Thanks.
-NIH just told us cancer vaccines in the UK hopefully within five years.
-Disciples pushing narrative of combo trials
-LP super quiet about anything beyond MAA submittal.
-No Chief of Commercialization
-No published management milestones beyond submission
-Surgeons do not appear to be freezing tumor samples. No marketing campaign.
All spells another trial before approval.
Yeah, but the point is you shouldn't have to. NWBO should've spelled it out assuming Smitty statement is true, of course.
Seems to me LP has done everything possible to make sure she doesn't lead investors beyond MAA submittal.
Instead of endlessly bitching about skeptics here don't you think your attention is better placed on management sending out a confusing PR. All they had to write was "The PIP trial can be deferred throughout the commercialization process". I hear they actually pay people for PR. LOL
That's not what NWBO's PR says. You should send them your info and ask that the PR be rewritten and released.
After submission not after approval.
>>The Company’s approved PIP includes a deferral under which the pediatric trials are anticipated to be undertaken AFTER an MAA application has been SUBMITTED.
Translation: No commercial approval until pediatric trials are run....Which is a really dumb rule when it comes to immunotherapies, IMO. Even if an immunotherapy works in adults it may not in children.
My apologies for posting stuff here about GBM.
Hey Mod, shouldn't Rhoids post be removed for ordering members to put other members on ignore?
On top of it all, I don't believe they were using the propper SOC survival figure, instead using an outdated 5%.
>>Glioblastoma (GBM) is the most common and aggressive malignant primary brain tumor in adults. Current treatment options for GBM include surgical resection, radiation, and chemotherapy, which predominantly slow cancer growth and reduce symptoms, resulting in a 5-year survival rate of no more than 10%.
https://www.nature.com/articles/s41435-024-00275-6
I always asked where's the compelling DCVAX data on dogs? They all called me crazy here.
https://www.fiercebiotech.com/research/glioblastoma-vaccine-turns-brain-tumors-cold-hot-humans-and-dogs
Looks like the Disciples took a bathroom break.
How's it possible that real shareholders would either not care or have no opinion on their lead investors? Makes no sense.
Just checking in. Have they PR'd any news yet of a confirmatory trial now that NIH has said to expect cancer vaccines in the UK in about five years?
The "Formulation" likely pertains to the degree of DC cell maturity when used with Polly. They are not combined into one, IMO.
Linda Powers never Cowers...
Oh wait, she does.
But continue to ignore the skeptics, you idiot.
GuruGary is a spiritless creature...Profits and losses don't exist.
Talk about anything but. Let's talk IP's today instead. Eye rolls.
Captain checkmated on that one. LOL
Is it Friday yet? .39 on its way.
Here's my best guess:
Bigger -Maybe still in it??
Joan -Out
Hemphill -Out
Hefner -Out
Thermo (whoever he is) -Out
Thank you all. Not an important subject, I guess. Better to discuss imaginary purchases all day than get to the bottom of who really owns what.